Aurinia Pharmaceuticals (IKAP) Revenue

1 Followers

Aurinia Pharmaceuticals Revenue

Aurinia Pharmaceuticals had a revenue of 83.22M in the quarter ending Jun 30, 2026, with 7.10%. This bring the company's revenue in the last twelve months to 311.51M, Decreased 4.43%. In the fiscal year ending Dec 31, 2025, Aurinia Pharmaceuticals had annual revenue of 283.06M with 20.38% growth.

Revenue (ttm)

311.51M

Revenue Growth

11.79%

P/S Ratio

6.52

Revenue/Employee

€2,211,367

Employees

128

Market Cap

€1.85B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	283.06M	47.92M	+20.38%
Dec 31, 2024	235.13M	59.62M	+33.97%
Dec 31, 2023	175.51M	41.48M	+30.95%
Dec 31, 2022	134.03M	88.42M	+193.89%
Dec 31, 2021	45.60M	-4.51M	-9.00%
Dec 31, 2020	50.12M	49.80M	+15,660.38%
Dec 31, 2019	318.00K	-145.00K	-31.32%
Dec 31, 2018	463.00K	43.00K	+10.24%
Dec 31, 2017	420.00K	―	―